BGI Genomics Co., Ltd. — Investor Relations & Filings
BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于持股5%以上股东减持计划期限届满暨实施情况的公告 | 2025-12-03 | Chinese | |
| 关于参加2025年度深圳辖区上市公司投资者网上集体接待日活动的公告 | 2025-11-13 | Chinese | |
| 关于高级管理人员辞任的公告 | 2025-11-12 | Chinese | |
| 2025年第二次临时股东会决议公告 | 2025-11-12 | Chinese | |
| 国浩律师（深圳）事务所关于深圳华大基因股份有限公司二〇二五年第二次临时股东会之法律意见书 | 2025-11-12 | Chinese | |
| 关于选举第四届董事会职工代表董事的公告 | 2025-11-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38373018 | 关于持股5%以上股东减持计划期限届满暨实施情况的公告 | 2025-12-03 | Chinese | ||
| 38372991 | 关于参加2025年度深圳辖区上市公司投资者网上集体接待日活动的公告 | 2025-11-13 | Chinese | ||
| 38372979 | 关于高级管理人员辞任的公告 | 2025-11-12 | Chinese | ||
| 38372965 | 2025年第二次临时股东会决议公告 | 2025-11-12 | Chinese | ||
| 38372938 | 国浩律师（深圳）事务所关于深圳华大基因股份有限公司二〇二五年第二次临时股东会之法律意见书 | 2025-11-12 | Chinese | ||
| 38372917 | 关于选举第四届董事会职工代表董事的公告 | 2025-11-12 | Chinese | ||
| 38372898 | 关于召开2025年第二次临时股东会的提示性公告 | 2025-11-07 | Chinese | ||
| 38372877 | 对外投资管理制度（2025年10月） | 2025-10-23 | Chinese | ||
| 38372866 | 累积投票制度实施细则（2025年10月） | 2025-10-23 | Chinese | ||
| 38372852 | 董事会薪酬与考核委员会工作细则（2025年10月） | 2025-10-23 | Chinese | ||
| 38372843 | 第四届董事会第七次会议决议公告 | 2025-10-23 | Chinese | ||
| 38372815 | 股东会议事规则（2025年10月） | 2025-10-23 | Chinese | ||
| 38372794 | 董事会审计委员会工作细则（2025年10月） | 2025-10-23 | Chinese | ||
| 38372782 | 募集资金管理制度（2025年10月） | 2025-10-23 | Chinese | ||
| 38372766 | 关联交易管理制度（2025年10月） | 2025-10-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BGI Genomics Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55655/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55655 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55655 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55655 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55655}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BGI Genomics Co., Ltd. (id: 55655)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.